Merck announced today positive topline data from its phase 3 CORALreef Lipids trial of enlicitide, an investigational oral PCSK9 inhibitor, in adults with hypercholesterolemia. The once-daily regimen achieved all primary and key secondary...
The BaxHTN phase III trial's full results were positive; patients with hard-to-control (uncontrolled and resistant) hypertension who received baxdrostat or placebo in addition to standard of care showed a statistically significant and clinically mean
Novartis reported encouraging findings from V-DIFFERENCE, a phase IV study comparing Leqvio (inclisiran) to a placebo, both of which were given in addition to individually tailored lipid-lowering therapy (LLT), in patients with hypercholesterolemia
In accordance with WHO guidelines, Zydus Lifesciences Ltd., a multinational healthcare organization that leads innovation, announced the introduction of its trivalent influenza (Flu) vaccine, VaxiFlu, for the first time in India. Every year, seasonal
Canon Medical Systems India Pvt. Ltd. has signed a Memorandum of Understanding (MoU) with Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) to enhance cancer diagnostics in India. This MoU introduces RGCIRC will deploy Canon’s flagship...
In order to determine whether zilebesiran, an RNAi therapy, might lower the risk of serious adverse cardiovascular events in patients with uncontrolled hypertension, Roche and Alnylam announced their intention to start a Phase III cardiovascular
Korber has announced the release of the new PAS-X MES 3.4, a robust upgrade to its Manufacturing Execution System that will facilitate the digital transformation of pharmaceutical manufacturing. The latest release includes a web-based and...
Care Hospitals, one of the country's leading healthcare providers, joined forces with Tech Mahindra to create a 24x7 multilingual call centre to ensure patient accessibility and redefine service standards in healthcare delivery. ..
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, GoI, in association with the Ministry of Commerce and Industry, GoI; Export Promotion Council for Medical Devices (EPCMD), and Central Drugs Standard Control Organisation
Novo Nordisk and Apollo Clinics have signed a strategic partnership to provide a comprehensive obesity control program in multiple Indian cities
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")